Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex

被引：1

作者：

Siegler, Aaron J. ^{[1
]}

Ahlschlager, Lauren ^{[1
]}

Rosenthal, Elizabeth M. ^{[2
,3
]}

Sullivan, Patrick S. ^{[2
]}

Kelley, Colleen F. ^{[4
]}

Rosenberg, Eli S. ^{[2
,3
]}

Sanchez, Travis H. ^{[2
]}

Moore, Renee H. ^{[5
]}

Mehta, C. Christina ^{[5
]}

Cecil, Michael P. ^{[6
]}

机构：

[1] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA

[2] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA

[3] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, One Univ Pl, Rensselaer, NY 12144 USA

[4] Emory Univ, Sch Med, 1648 Pierce Dr NE, Atlanta, GA 30307 USA

[5] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, 1518 Clifton Rd NE, Atlanta, GA 30322 USA

[6] TheyFit LLC, 4140 Tate St NE, Covington, GA 30014 USA

来源：

SEXUAL HEALTH | 2020年 / 17卷 / 01期

基金：

美国国家卫生研究院;

关键词：

HIV; prevention; sexual and gender minorities; HIV;

D O I：

10.1071/SH18152

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Condoms are highly effective for HIV prevention, yet are not currently indicated by the US Food and Drug Administration (FDA) for anal sex. We surveyed a national sample of men who have sex with men to assess whether FDA label indication could affect anticipated condom use, and to determine levels of perceived condom failure for anal sex. We found that 69% of respondents anticipated that a label indication change would increase their likelihood of condom use. Median perceived failure was 15%. We anticipate that these results may aid the FDA in developing standards for a label indication for anal sex.

引用

页码：91 / 95

页数：5

共 50 条

[1] Time for the US food and drug administration approval of condoms for anal intercourse
Nguyen, Brian T.
Nelson, Anita L.
[J]. ECLINICALMEDICINE, 2019, 17
[2] US Food and Drug Administration's (FDA) safety assessment of food ingredients
Thurmond, Scott
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[3] US Food and Drug Administration (FDA) to conduct a review of the safety of orlistat
Idris, Iskandar
[J]. DIABETES OBESITY & METABOLISM, 2009, 11 (11): : 1089 - 1089
[4] Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)
White, Nicholas J.
Watson, James A.
Simpson, Julie A.
[J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (02) : 358 - 358
[5] Accelerated approval of Iressa from FDA news releases (FDA US Food and Drug Administration)
Shimada, Y
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (07) : 369 - 369
[6] The US Food and Drug Administration (FDA) Food Disaggregation Database (FDA-FDD): a new tool for US dietary exposure assessment
Spungen, Judith H.
Shimizu, Miyuki
Jarman, Dwayne
Farakos, Sofia M. Santillana
[J]. FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2024,
[7] What Is US Food and Drug Administration Looking for to Assess and Label Risk?
Taylor, L. G.
[J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2016, 106 (05) : 382 - 382
[8] Molecular Health grants SafetyMAP™-License to the US Food and Drug Administration (FDA)
不详
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (12) : 711 - 711
[9] Use of reality "female condoms" for anal sex by US men who have sex with men
Gross, M
Buchbinder, SP
Holte, S
Celum, CL
Koblin, BA
Douglas, JM
[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (11) : 1739 - 1741
[10] Review times for ophthalmic new drug applications (NDAs) at the US Food and Drug Administration (FDA).
Novack, GD
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1346 - 1346

← 1 2 3 4 5 →